Homo sapiens Protein: HEPACAM | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||
InnateDB Protein | IDBP-75355.6 | ||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||
Gene Symbol | HEPACAM | ||||||||||
Protein Name | hepatic and glial cell adhesion molecule | ||||||||||
Synonyms | |||||||||||
Species | Homo sapiens | ||||||||||
Ensembl Protein | ENSP00000298251 | ||||||||||
InnateDB Gene | IDBG-75353 (HEPACAM) | ||||||||||
Protein Structure | |||||||||||
UniProt Annotation | |||||||||||
Function | Involved in regulating cell motility and cell-matrix interactions. May inhibit cell growth through suppression of cell proliferation. {ECO:0000269PubMed:15885354, ECO:0000269PubMed:15917256}. | ||||||||||
Subcellular Localization | Cytoplasm {ECO:0000269PubMed:15885354, ECO:0000269PubMed:15917256}. Membrane; Single-pass type I membrane protein; Cytoplasmic side {ECO:0000269PubMed:15885354, ECO:0000269PubMed:15917256}. Note=In MCF-7 breast carcinoma and hepatic Hep 3B2.1-7 and Hep-G2 cell lines, localization of HEPACAM is cell density-dependent. In well spread cells, localized to punctate structures in the perinuclear membrane, cytoplasm, and at cell surface of protusions. In confluent cells, localized predominantly to the cytoplasmic membrane, particularly in areas of cell-cell contacts. Colocalizes with CDH1. | ||||||||||
Disease Associations | Leukoencephalopathy, megalencephalic, with subcortical cysts, 2A (MLC2A) [MIM:613925]: A neurodegenerative disorder characterized by infantile-onset macrocephaly and later onset of motor deterioration, with ataxia and spasticity, seizures, and cognitive decline of variable severity. The brain appears swollen on magnetic resonance imaging with white-matter abnormalities and subcortical cysts, in all stages of the disease. {ECO:0000269PubMed:21419380}. Note=The disease is caused by mutations affecting the gene represented in this entry.Leukoencephalopathy, megalencephalic, with subcortical cysts, 2B (MLC2B) [MIM:613926]: A neurodegenerative disorder characterized by infantile-onset of macrocephaly and mildly delayed motor development associated with white-matter abnormalities on brain magnetic resonance imaging. The phenotype is milder that MLC2A, with better preserved cerebellar white matter and no subcortical cysts outside the temporal region. On follow-up, patients show normal or almost normal motor function. Some patients have normal intelligence, whereas others have a significant cognitive deficiency. {ECO:0000269PubMed:21419380}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||
Tissue Specificity | |||||||||||
Comments | |||||||||||
Interactions | |||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
|
||||||||||
Gene Ontology | |||||||||||
Molecular Function |
|
||||||||||
Biological Process |
|
||||||||||
Cellular Component |
|
||||||||||
Protein Structure and Domains | |||||||||||
PDB ID | |||||||||||
InterPro |
IPR003598
Immunoglobulin subtype 2 IPR003599 Immunoglobulin subtype IPR007110 Immunoglobulin-like domain IPR013098 Immunoglobulin I-set IPR013106 Immunoglobulin V-set domain IPR013151 Immunoglobulin |
||||||||||
PFAM |
PF07679
PF07686 PF00047 |
||||||||||
PRINTS | |||||||||||
PIRSF | |||||||||||
SMART |
SM00408
SM00409 |
||||||||||
TIGRFAMs | |||||||||||
Post-translational Modifications | |||||||||||
Modification | |||||||||||
Cross-References | |||||||||||
SwissProt | Q14CZ8 | ||||||||||
PhosphoSite | PhosphoSite-Q14CZ8 | ||||||||||
TrEMBL | |||||||||||
UniProt Splice Variant | |||||||||||
Entrez Gene | 641654 | ||||||||||
UniGene | Hs.740938 | ||||||||||
RefSeq | NP_689935 | ||||||||||
HUGO | HGNC:26361 | ||||||||||
OMIM | 611642 | ||||||||||
CCDS | CCDS8456 | ||||||||||
HPRD | 08068 | ||||||||||
IMGT | |||||||||||
EMBL | AK098396 AK122595 AL834419 AY047587 BC104831 BC113562 | ||||||||||
GenPept | AAI04832 AAI13563 AAQ93018 BAC05297 BAC85486 CAD39081 | ||||||||||